Cargando…

Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values

We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Qui...

Descripción completa

Detalles Bibliográficos
Autores principales: Niepsuj, Justyna, Franik, Grzegorz, Madej, Paweł, Piwowar, Agnieszka, Bizoń, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328171/
https://www.ncbi.nlm.nih.gov/pubmed/35884870
http://dx.doi.org/10.3390/biomedicines10071564
_version_ 1784757653095841792
author Niepsuj, Justyna
Franik, Grzegorz
Madej, Paweł
Piwowar, Agnieszka
Bizoń, Anna
author_facet Niepsuj, Justyna
Franik, Grzegorz
Madej, Paweł
Piwowar, Agnieszka
Bizoń, Anna
author_sort Niepsuj, Justyna
collection PubMed
description We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Quicki). We chose oxidized low-density lipoproteins (oxLDL-C) as a marker of oxidative stress and the ferric reducing ability of plasma (FRAP) as a marker of antioxidant status. In women with PCOS, the values of BMI, WHR, age and concentration of glucose significantly affected oxLDL-C concentration and FRAP values. FRAP correlated with oxLDL-C level in the whole group and in women who were insulin sensitive (HOMA-IR < 2.0). There was a negative relationship between the concentration of Anti-Müllerian hormone and both oxLDL-C and FRAP. Furthermore, the value of FRAP was inversely correlated with luteinizing hormone (LH), follicle-stimulating hormone (FSH) and androstenedione, whereas it was positively correlated with the LH/FSH ratio. The concentration of oxLDL and the value of FRAP are significantly associated with selected metabolic and hormonal parameters in the course of PCOS.
format Online
Article
Text
id pubmed-9328171
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93281712022-07-28 Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values Niepsuj, Justyna Franik, Grzegorz Madej, Paweł Piwowar, Agnieszka Bizoń, Anna Biomedicines Article We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Quicki). We chose oxidized low-density lipoproteins (oxLDL-C) as a marker of oxidative stress and the ferric reducing ability of plasma (FRAP) as a marker of antioxidant status. In women with PCOS, the values of BMI, WHR, age and concentration of glucose significantly affected oxLDL-C concentration and FRAP values. FRAP correlated with oxLDL-C level in the whole group and in women who were insulin sensitive (HOMA-IR < 2.0). There was a negative relationship between the concentration of Anti-Müllerian hormone and both oxLDL-C and FRAP. Furthermore, the value of FRAP was inversely correlated with luteinizing hormone (LH), follicle-stimulating hormone (FSH) and androstenedione, whereas it was positively correlated with the LH/FSH ratio. The concentration of oxLDL and the value of FRAP are significantly associated with selected metabolic and hormonal parameters in the course of PCOS. MDPI 2022-06-30 /pmc/articles/PMC9328171/ /pubmed/35884870 http://dx.doi.org/10.3390/biomedicines10071564 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Niepsuj, Justyna
Franik, Grzegorz
Madej, Paweł
Piwowar, Agnieszka
Bizoń, Anna
Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
title Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
title_full Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
title_fullStr Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
title_full_unstemmed Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
title_short Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
title_sort evaluation of pro/antioxidant imbalance in blood of women with polycystic ovary syndrome based on determination of oxidized low-density lipoproteins and ferric reducing ability of plasma values
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328171/
https://www.ncbi.nlm.nih.gov/pubmed/35884870
http://dx.doi.org/10.3390/biomedicines10071564
work_keys_str_mv AT niepsujjustyna evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues
AT franikgrzegorz evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues
AT madejpaweł evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues
AT piwowaragnieszka evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues
AT bizonanna evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues